Training Tuesday!
Join us in celebrating our CaRE2 Early Stage Investigator, Askal Ali. 🧪🔬👩🏽🔬 #CancerResearch #CaRE2 #CaRE2HEC #CaRE2ESI #TrainingTuesday
Happy Juneteenth!
Congratulation to Dr. Janice Krieger
Congratulations🎉 CaRE2 PI, Janice Krieger, was named to the International Communication Association Fellows Class of 2023, one of the most prestigious honors in communication research. Read more here: https://ow.ly/AbEF50OQnYl
Training Tuesday!
Join us in celebrating our CaRE2 Graduate Student, Diego Velarde. 🧪🔬👩🏽🔬 #CancerResearch #CaRE2 #CaRE2HEC #TrainingTuesday
National Cancer Survivor Month
Join us in celebrating National Cancer Survivor Month this June🎉 #CaRE2HEC #NationalCancerSurvivorMonth #CelebrateSurvivors #CancerResearch
What is a Clinical Trial?
Learn about what cancer clinical trials are and the phases of clinical trials, which in turn bring about new cancer treatments. 👨⚕️🧑🏿⚕️
Hammer & Nails West Hollywood – Celebrating Father’s & Health
Join our Community Outreach Core Team on Saturday June 17th at the Hammer & Nails West Hollywood Father’s Day event. Stop by our booth to learn about our CaRE2 Community Registry! #CaRE2 #CancerResearch #LosAngeles #FathersDayEvent #WestHollywood #CaRE2HEC
Festival of Life
On Saturday, June 3rd, 2023, USC’s COE and COC team members participated in the 33rd Annual Festival of Life, providing the community with cancer resources and information. This event celebrates the strength and courage of cancer survivors and their families.
Caravan of Hope
On Saturday, June 3rd, 2023, our COC team supported Celebrate Life Cancer Ministry in their Caravan of Hope Event, hosted by our Community Scientist Alumni Pastor Rhonda, to celebrate all cancer survivors and raise awareness on cancer prevention, treatment and risks.
Feature Friday – Breast Cancer Survivorship Program
It’s #NationalCancerSurvivorsmonth! We would like to celebrate by highlighting the Eileen McGeever Breast Cancer Survivorship program, a multi-ethnic program that integrates research and survivorship education. The program is developing a new blood-based test to identify residual disease that may be undetected by mammograms or other forms of imaging. Doing so will help us identify early breast […]